WallStreetZenWallStreetZen

NASDAQ: APVO
Aptevo Therapeutics Inc Earnings & Revenue

APVO past revenue growth

How has APVO's revenue growth performed historically?
Company
N/A
Industry
89.89%
Market
19.72%
APVO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
APVO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

APVO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$27.0M
Current Profit Margin
0%

APVO Return on Equity

Current Company
-219.2%
Current Industry
16.8%
Current Market
28.2%
APVO's Return on Equity (-219.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when APVO announces earnings.

APVO Return on Assets

Current Company
-109.7%
Current Industry
3.2%
APVO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

APVO Return on Capital Employed

Current Company
-238.45%
Current Industry
-42.4%
APVO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

APVO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
APVO$0.00-$26.52M-$27.02M-100.00%N/A
VRPX$0.00-$16.89M-$16.89MN/AN/A
SEEL$1.97M-$26.97M-$27.12M+51.47%N/A
SLRX$0.00-$8.91M-$8.92M-100.00%N/A
DRMA$0.00-$8.69M-$8.69MN/AN/A

APVO earnings dates

Next earnings date
Aug 8, 2024

Aptevo Therapeutics Earnings & Revenue FAQ

What were APVO's earnings last quarter?

On Invalid Date, Aptevo Therapeutics (NASDAQ: APVO) reported Q1 2024 earnings per share (EPS) of -$9.95, up 157.25% year over year. Total Aptevo Therapeutics earnings for the quarter were -$6.83 million. In the same quarter last year, Aptevo Therapeutics's earnings per share (EPS) was $17.38.

If you're new to stock investing, here's how to buy Aptevo Therapeutics stock.

What was APVO's earnings growth in the past year?

As of Q3 2024, Aptevo Therapeutics's earnings has grown year over year. Aptevo Therapeutics's earnings in the past year totalled -$27.02 million.

What is APVO's earnings date?

Aptevo Therapeutics's earnings date is Invalid Date. Add APVO to your watchlist to be reminded of APVO's next earnings announcement.

What was APVO's revenue last quarter?

On Invalid Date, Aptevo Therapeutics (NASDAQ: APVO) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Aptevo Therapeutics's revenue was $0.00.

What was APVO's revenue growth in the past year?

As of Q3 2024, Aptevo Therapeutics's revenue has grown null year over year. Aptevo Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.